Question 1

Do analysts rate CGBD or CCAP?

Accepted Answer

Carlyle Secured Lending presently has a consensus target price of $12.50, indicating a potential upside of 17.26%. Crescent Capital BDC has a consensus target price of $14.30, indicating a potential upside of 26.33%. Given Crescent Capital BDC's higher possible upside, analysts clearly believe Crescent Capital BDC is more favorable than Carlyle Secured Lending. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Carlyle Secured Lending 0 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.43 Crescent Capital BDC 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17

Question 2

Is CGBD or CCAP a better dividend stock?

Accepted Answer

Carlyle Secured Lending pays an annual dividend of $1.60 per share and has a dividend yield of 15.0%. Crescent Capital BDC pays an annual dividend of $1.68 per share and has a dividend yield of 14.8%. Carlyle Secured Lending pays out 225.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC pays out 409.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has increased its dividend for 1 consecutive years. Carlyle Secured Lending is clearly the better dividend stock, given its higher yield and lower payout ratio.

Question 3

Which has stronger valuation & earnings, CGBD or CCAP?

Accepted Answer

Carlyle Secured Lending has higher revenue and earnings than Crescent Capital BDC. Carlyle Secured Lending is trading at a lower price-to-earnings ratio than Crescent Capital BDC, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Carlyle Secured Lending $255.57M 2.90 $69.97M $0.71 15.01 Crescent Capital BDC $167.29M 2.49 $34.51M $0.41 27.61

Question 4

Do institutionals & insiders hold more shares of CGBD or CCAP?

Accepted Answer

24.5% of Carlyle Secured Lending shares are held by institutional investors. Comparatively, 49.5% of Crescent Capital BDC shares are held by institutional investors. 0.6% of Carlyle Secured Lending shares are held by company insiders. Comparatively, 1.2% of Crescent Capital BDC shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Question 5

Is CGBD or CCAP more profitable?

Accepted Answer

Carlyle Secured Lending has a net margin of 19.52% compared to Crescent Capital BDC's net margin of 9.26%. Crescent Capital BDC's return on equity of 9.34% beat Carlyle Secured Lending's return on equity. Company Net Margins Return on Equity Return on Assets Carlyle Secured Lending 19.52% 8.99% 4.01% Crescent Capital BDC 9.26% 9.34% 4.04%

Question 6

Which has more volatility & risk, CGBD or CCAP?

Accepted Answer

Carlyle Secured Lending has a beta of 0.62, indicating that its stock price is 38% less volatile than the broader market. Comparatively, Crescent Capital BDC has a beta of 0.52, indicating that its stock price is 48% less volatile than the broader market.

Question 7

Does the media prefer CGBD or CCAP?

Accepted Answer

In the previous week, Crescent Capital BDC had 5 more articles in the media than Carlyle Secured Lending. MarketBeat recorded 7 mentions for Crescent Capital BDC and 2 mentions for Carlyle Secured Lending. Carlyle Secured Lending's average media sentiment score of 1.56 beat Crescent Capital BDC's score of 0.67 indicating that Carlyle Secured Lending is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Carlyle Secured Lending 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Crescent Capital BDC 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Question 8

Do analysts recommend CCAP or MFIC?

Accepted Answer

Crescent Capital BDC presently has a consensus target price of $14.30, suggesting a potential upside of 26.33%. MidCap Financial Investment has a consensus target price of $11.54, suggesting a potential upside of 9.45%. Given Crescent Capital BDC's higher probable upside, analysts plainly believe Crescent Capital BDC is more favorable than MidCap Financial Investment. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Crescent Capital BDC 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17 MidCap Financial Investment 0 Sell rating(s) 7 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.22

Question 9

Is CCAP or MFIC a better dividend stock?

Accepted Answer

Crescent Capital BDC pays an annual dividend of $1.68 per share and has a dividend yield of 14.8%. MidCap Financial Investment pays an annual dividend of $1.24 per share and has a dividend yield of 11.8%. Crescent Capital BDC pays out 409.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. MidCap Financial Investment pays out 3,100.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has increased its dividend for 1 consecutive years. Crescent Capital BDC is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Question 10

Which has stronger valuation and earnings, CCAP or MFIC?

Accepted Answer

MidCap Financial Investment has lower revenue, but higher earnings than Crescent Capital BDC. Crescent Capital BDC is trading at a lower price-to-earnings ratio than MidCap Financial Investment, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Crescent Capital BDC $167.29M 2.49 $34.51M $0.41 27.61 MidCap Financial Investment $22.82M 38.05 $63.17M $0.04 263.50

Question 11

Do insiders & institutionals have more ownership in CCAP or MFIC?

Accepted Answer

49.5% of Crescent Capital BDC shares are owned by institutional investors. Comparatively, 28.5% of MidCap Financial Investment shares are owned by institutional investors. 1.2% of Crescent Capital BDC shares are owned by company insiders. Comparatively, 0.8% of MidCap Financial Investment shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Question 12

Is CCAP or MFIC more profitable?

Accepted Answer

Crescent Capital BDC has a net margin of 9.26% compared to MidCap Financial Investment's net margin of 1.90%. MidCap Financial Investment's return on equity of 10.86% beat Crescent Capital BDC's return on equity. Company Net Margins Return on Equity Return on Assets Crescent Capital BDC 9.26% 9.34% 4.04% MidCap Financial Investment 1.90% 10.86% 4.31%

Question 13

Which has more volatility and risk, CCAP or MFIC?

Accepted Answer

Crescent Capital BDC has a beta of 0.52, suggesting that its share price is 48% less volatile than the broader market. Comparatively, MidCap Financial Investment has a beta of 0.59, suggesting that its share price is 41% less volatile than the broader market.

Question 14

Does the media refer more to CCAP or MFIC?

Accepted Answer

In the previous week, Crescent Capital BDC had 6 more articles in the media than MidCap Financial Investment. MarketBeat recorded 7 mentions for Crescent Capital BDC and 1 mentions for MidCap Financial Investment. MidCap Financial Investment's average media sentiment score of 1.89 beat Crescent Capital BDC's score of 0.67 indicating that MidCap Financial Investment is being referred to more favorably in the news media. Company Overall Sentiment Crescent Capital BDC Positive MidCap Financial Investment Very Positive

Question 15

Do analysts rate BCSF or CCAP?

Accepted Answer

Bain Capital Specialty Finance presently has a consensus price target of $14.00, suggesting a potential upside of 8.61%. Crescent Capital BDC has a consensus price target of $14.30, suggesting a potential upside of 26.33%. Given Crescent Capital BDC's higher possible upside, analysts plainly believe Crescent Capital BDC is more favorable than Bain Capital Specialty Finance. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bain Capital Specialty Finance 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Crescent Capital BDC 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17

Question 16

Is BCSF or CCAP a better dividend stock?

Accepted Answer

Bain Capital Specialty Finance pays an annual dividend of $1.68 per share and has a dividend yield of 13.0%. Crescent Capital BDC pays an annual dividend of $1.68 per share and has a dividend yield of 14.8%. Bain Capital Specialty Finance pays out 147.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC pays out 409.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Bain Capital Specialty Finance has increased its dividend for 4 consecutive years and Crescent Capital BDC has increased its dividend for 1 consecutive years.

Question 17

Which has better earnings and valuation, BCSF or CCAP?

Accepted Answer

Bain Capital Specialty Finance has higher revenue and earnings than Crescent Capital BDC. Bain Capital Specialty Finance is trading at a lower price-to-earnings ratio than Crescent Capital BDC, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Bain Capital Specialty Finance $273.24M 3.06 $98.76M $1.14 11.31 Crescent Capital BDC $167.29M 2.49 $34.51M $0.41 27.61

Question 18

Do institutionals and insiders believe in BCSF or CCAP?

Accepted Answer

49.5% of Crescent Capital BDC shares are held by institutional investors. 0.6% of Bain Capital Specialty Finance shares are held by insiders. Comparatively, 1.2% of Crescent Capital BDC shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Question 19

Is BCSF or CCAP more profitable?

Accepted Answer

Bain Capital Specialty Finance has a net margin of 27.00% compared to Crescent Capital BDC's net margin of 9.26%. Bain Capital Specialty Finance's return on equity of 10.44% beat Crescent Capital BDC's return on equity. Company Net Margins Return on Equity Return on Assets Bain Capital Specialty Finance 27.00% 10.44% 4.35% Crescent Capital BDC 9.26% 9.34% 4.04%

Question 20

Which has more risk & volatility, BCSF or CCAP?

Accepted Answer

Bain Capital Specialty Finance has a beta of 0.57, meaning that its share price is 43% less volatile than the broader market. Comparatively, Crescent Capital BDC has a beta of 0.52, meaning that its share price is 48% less volatile than the broader market.

Question 21

Does the media refer more to BCSF or CCAP?

Accepted Answer

In the previous week, Crescent Capital BDC had 7 more articles in the media than Bain Capital Specialty Finance. MarketBeat recorded 7 mentions for Crescent Capital BDC and 0 mentions for Bain Capital Specialty Finance. Crescent Capital BDC's average media sentiment score of 0.67 beat Bain Capital Specialty Finance's score of 0.50 indicating that Crescent Capital BDC is being referred to more favorably in the news media. Company Overall Sentiment Bain Capital Specialty Finance Positive Crescent Capital BDC Positive

Question 22

Do analysts prefer GSBD or CCAP?

Accepted Answer

Goldman Sachs BDC currently has a consensus target price of $9.17, suggesting a potential upside of 2.54%. Crescent Capital BDC has a consensus target price of $14.30, suggesting a potential upside of 26.33%. Given Crescent Capital BDC's stronger consensus rating and higher probable upside, analysts plainly believe Crescent Capital BDC is more favorable than Goldman Sachs BDC. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Goldman Sachs BDC 2 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67 Crescent Capital BDC 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17

Question 23

Is GSBD or CCAP a better dividend stock?

Accepted Answer

Goldman Sachs BDC pays an annual dividend of $1.28 per share and has a dividend yield of 14.3%. Crescent Capital BDC pays an annual dividend of $1.68 per share and has a dividend yield of 14.8%. Goldman Sachs BDC pays out 196.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC pays out 409.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has raised its dividend for 1 consecutive years. Crescent Capital BDC is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Question 24

Which has preferable earnings & valuation, GSBD or CCAP?

Accepted Answer

Goldman Sachs BDC has higher revenue and earnings than Crescent Capital BDC. Goldman Sachs BDC is trading at a lower price-to-earnings ratio than Crescent Capital BDC, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Goldman Sachs BDC $365.57M 2.75 $119.27M $0.65 13.75 Crescent Capital BDC $167.29M 2.49 $34.51M $0.41 27.61

Question 25

Do institutionals & insiders have more ownership in GSBD or CCAP?

Accepted Answer

28.7% of Goldman Sachs BDC shares are held by institutional investors. Comparatively, 49.5% of Crescent Capital BDC shares are held by institutional investors. 0.1% of Goldman Sachs BDC shares are held by company insiders. Comparatively, 1.2% of Crescent Capital BDC shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Question 26

Is GSBD or CCAP more profitable?

Accepted Answer

Goldman Sachs BDC has a net margin of 21.32% compared to Crescent Capital BDC's net margin of 9.26%. Goldman Sachs BDC's return on equity of 10.94% beat Crescent Capital BDC's return on equity. Company Net Margins Return on Equity Return on Assets Goldman Sachs BDC 21.32% 10.94% 4.66% Crescent Capital BDC 9.26% 9.34% 4.04%

Question 27

Which has more risk and volatility, GSBD or CCAP?

Accepted Answer

Goldman Sachs BDC has a beta of 0.58, meaning that its stock price is 42% less volatile than the broader market. Comparatively, Crescent Capital BDC has a beta of 0.52, meaning that its stock price is 48% less volatile than the broader market.

Question 28

Does the media prefer GSBD or CCAP?

Accepted Answer

In the previous week, Crescent Capital BDC had 5 more articles in the media than Goldman Sachs BDC. MarketBeat recorded 7 mentions for Crescent Capital BDC and 2 mentions for Goldman Sachs BDC. Crescent Capital BDC's average media sentiment score of 0.67 beat Goldman Sachs BDC's score of 0.00 indicating that Crescent Capital BDC is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Goldman Sachs BDC 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Crescent Capital BDC 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Question 29

Do analysts rate CCAP or OBDC?

Accepted Answer

Crescent Capital BDC currently has a consensus price target of $14.30, suggesting a potential upside of 26.33%. Blue Owl Capital has a consensus price target of $13.00, suggesting a potential upside of 19.05%. Given Crescent Capital BDC's higher probable upside, research analysts plainly believe Crescent Capital BDC is more favorable than Blue Owl Capital. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Crescent Capital BDC 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17 Blue Owl Capital 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.75

Question 30

Is CCAP or OBDC a better dividend stock?

Accepted Answer

Crescent Capital BDC pays an annual dividend of $1.68 per share and has a dividend yield of 14.8%. Blue Owl Capital pays an annual dividend of $1.48 per share and has a dividend yield of 13.6%. Crescent Capital BDC pays out 409.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Blue Owl Capital pays out 211.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has increased its dividend for 1 consecutive years and Blue Owl Capital has increased its dividend for 2 consecutive years.

Question 31

Which has stronger valuation & earnings, CCAP or OBDC?

Accepted Answer

Blue Owl Capital has higher revenue and earnings than Crescent Capital BDC. Blue Owl Capital is trading at a lower price-to-earnings ratio than Crescent Capital BDC, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Crescent Capital BDC $167.29M 2.49 $34.51M $0.41 27.61 Blue Owl Capital $1.85B 2.93 $800.36M $0.70 15.60

Question 32

Do institutionals & insiders have more ownership in CCAP or OBDC?

Accepted Answer

49.5% of Crescent Capital BDC shares are held by institutional investors. Comparatively, 42.8% of Blue Owl Capital shares are held by institutional investors. 1.2% of Crescent Capital BDC shares are held by insiders. Comparatively, 0.1% of Blue Owl Capital shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Question 33

Is CCAP or OBDC more profitable?

Accepted Answer

Blue Owl Capital has a net margin of 20.21% compared to Crescent Capital BDC's net margin of 9.26%. Blue Owl Capital's return on equity of 9.76% beat Crescent Capital BDC's return on equity. Company Net Margins Return on Equity Return on Assets Crescent Capital BDC 9.26% 9.34% 4.04% Blue Owl Capital 20.21% 9.76% 4.27%

Question 34

Which has more volatility and risk, CCAP or OBDC?

Accepted Answer

Crescent Capital BDC has a beta of 0.52, indicating that its share price is 48% less volatile than the broader market. Comparatively, Blue Owl Capital has a beta of 0.62, indicating that its share price is 38% less volatile than the broader market.

Question 35

Does the media refer more to CCAP or OBDC?

Accepted Answer

In the previous week, Crescent Capital BDC had 4 more articles in the media than Blue Owl Capital. MarketBeat recorded 7 mentions for Crescent Capital BDC and 3 mentions for Blue Owl Capital. Blue Owl Capital's average media sentiment score of 1.14 beat Crescent Capital BDC's score of 0.67 indicating that Blue Owl Capital is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Crescent Capital BDC 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Blue Owl Capital 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Metric	Crescent Capital BDC	FIN Industry	Finance Sector	NASDAQ Exchange
Market Cap	$417.14M	$1.30B	$13.42B	$12.49B
Dividend Yield	14.36%	12.97%	5.78%	5.30%
P/E Ratio	27.61	10.96	19.79	24.34
Price / Sales	2.49	16.14	139.28	125.86
Price / Cash	6.82	7.17	19.93	57.88
Price / Book	0.59	0.77	2.18	6.76
Net Income	$34.51M	$121.13M	$1.13B	$337.09M
7 Day Performance	-0.53%	-0.54%	-0.33%	1.50%
1 Month Performance	-18.74%	-7.48%	-0.07%	6.18%
1 Year Performance	-24.13%	-20.93%	11.66%	35.62%

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CCAP Crescent Capital BDC	4.9388 of 5 stars	$11.32 -2.7%	$14.30 +26.3%	-22.8%	$417.14M	$167.29M	27.61	N/A
CGBD Carlyle Secured Lending	4.2019 of 5 stars	$10.76 +0.7%	$12.50 +16.2%	-21.1%	$747.82M	$255.57M	15.16	N/A	Positive News
MFIC MidCap Financial Investment	2.9441 of 5 stars	$10.71 +1.0%	$11.54 +7.7%	-15.9%	$882.18M	$320.88M	267.82	N/A	Positive News
BCSF Bain Capital Specialty Finance	2.0164 of 5 stars	$13.37 +1.2%	$14.00 +4.7%	-14.2%	$867.31M	$273.24M	11.73	1,000
GSBD Goldman Sachs BDC	2.7733 of 5 stars	$8.89 +0.3%	$9.17 +3.1%	-18.8%	$1.00B	$365.57M	13.68	N/A

Crescent Capital BDC (CCAP) Competitors

CCAP vs. CGBD, MFIC, BCSF, GSBD, and OBDC

How does Crescent Capital BDC compare to Carlyle Secured Lending?

Summary

How does Crescent Capital BDC compare to MidCap Financial Investment?

Summary

How does Crescent Capital BDC compare to Bain Capital Specialty Finance?

Summary

How does Crescent Capital BDC compare to Goldman Sachs BDC?

Summary

How does Crescent Capital BDC compare to Blue Owl Capital?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCAP vs. The Competition

Crescent Capital BDC Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Crescent Capital BDC (CCAP) Competitors

CCAP vs. CGBD, MFIC, BCSF, GSBD, and OBDC

How does Crescent Capital BDC compare to Carlyle Secured Lending?

Is CGBD or CCAP a better dividend stock?

Do institutionals & insiders hold more shares of CGBD or CCAP?

Do analysts rate CGBD or CCAP?

Which has more volatility & risk, CGBD or CCAP?

Is CGBD or CCAP more profitable?

Which has stronger valuation & earnings, CGBD or CCAP?

Does the media prefer CGBD or CCAP?

Summary

How does Crescent Capital BDC compare to MidCap Financial Investment?

Is CCAP or MFIC a better dividend stock?

Which has stronger valuation and earnings, CCAP or MFIC?

Is CCAP or MFIC more profitable?

Do insiders & institutionals have more ownership in CCAP or MFIC?

Do analysts recommend CCAP or MFIC?

Does the media refer more to CCAP or MFIC?

Which has more volatility and risk, CCAP or MFIC?

Summary

How does Crescent Capital BDC compare to Bain Capital Specialty Finance?

Which has better earnings and valuation, BCSF or CCAP?

Is BCSF or CCAP more profitable?

Is BCSF or CCAP a better dividend stock?

Do institutionals and insiders believe in BCSF or CCAP?

Does the media refer more to BCSF or CCAP?

Do analysts rate BCSF or CCAP?

Which has more risk & volatility, BCSF or CCAP?

Summary

How does Crescent Capital BDC compare to Goldman Sachs BDC?

Which has more risk and volatility, GSBD or CCAP?

Is GSBD or CCAP a better dividend stock?

Do analysts prefer GSBD or CCAP?

Is GSBD or CCAP more profitable?

Do institutionals & insiders have more ownership in GSBD or CCAP?

Does the media prefer GSBD or CCAP?

Which has preferable earnings & valuation, GSBD or CCAP?

Summary

How does Crescent Capital BDC compare to Blue Owl Capital?

Which has more volatility and risk, CCAP or OBDC?

Do institutionals & insiders have more ownership in CCAP or OBDC?

Is CCAP or OBDC more profitable?

Is CCAP or OBDC a better dividend stock?

Do analysts rate CCAP or OBDC?

Does the media refer more to CCAP or OBDC?

Which has stronger valuation & earnings, CCAP or OBDC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCAP vs. The Competition

Crescent Capital BDC Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools